South Korea Contraceptive Market Overview, 2030

The South Korean contraceptive market is a fascinating blend of historical conservatism and a burgeoning demand for modern, convenient options, all unfolding against the backdrop of one of the world's lowest birth rates. This report aims to provide a sharp, comprehensive overview of this unique market, dissecting its intricate dynamics and pinpointing the subtle yet significant growth opportunities that are increasingly emerging. A rising awareness of reproductive health and the importance of family planning, particularly among younger generations, is becoming a significant force. This is increasingly coupled with women's growing participation in the workforce, driving a demand for more reliable and convenient birth control methods that fit their lifestyles. The increasing prevalence of sexually transmitted infections among adolescents and young adults in South Korea highlights the critical role of barrier methods like condoms, which are broadly accepted and easily accessible. Innovations in contraceptive methods, such as the introduction of new, lower-dose hormonal formulations and the growing acceptance of subdermal implants, are slowly expanding the basket of choices available to South Korean women. The South Korean government, recognizing the need for comprehensive reproductive healthcare, is increasingly supportive of policies that aim to expand access to various contraceptive products. While historically cautious, recent shifts suggest a greater openness to modern methods. The general availability of healthcare services and family planning programs through clinics and hospitals is well-established, contributing to market penetration. Societal norms and cultural acceptance, often rooted in Confucian traditions, still place a disproportionate responsibility for contraception on women, and open discussions about sexual health can remain somewhat taboo. The rising awareness of family planning and reproductive health is a consistent driver across the region, including South Korea. Government initiatives and funding for family planning programs exist, and South Korea is a commitment maker to global family planning goals (FP2030), emphasizing improved healthcare access. The growing prevalence of STIs continues to drive demand for barrier methods.

According to the research report, “South Korea Contraceptive Market Overview, 2030,"" published by Bonafide Research, the South Korea Contraceptive market is anticipated to add to more than USD 180 Million by 2025–30. The competitive landscape of the South Korean contraceptive market is shaped by a mix of leading global pharmaceutical companies and established domestic players, all navigating a market that, while growing, remains influenced by unique local preferences and regulatory frameworks. Major international companies such as Bayer AG, Organon, Pfizer Inc., and Church & Dwight Co., Inc. hold significant market share, particularly in the hormonal contraceptive and condom segments. These companies continuously invest in research and development to introduce new product formulations and delivery systems, alongside strategic marketing initiatives tailored to the South Korean cultural context. Domestic pharmaceutical companies, alongside local condom manufacturers, also play a vital role, often leveraging their strong understanding of the local market and established distribution networks. The contraceptive supply chain in South Korea is generally efficient and well-regulated. Products are either imported by multinational corporations or manufactured domestically, then distributed through a robust network involving major pharmaceutical wholesalers, who supply to a multitude of retail pharmacies, hospital pharmacies, and increasingly, online platforms. Contraceptives are also provided directly through clinics and medical institutions where consultations and procedures take place. There were recommendations to develop guidelines for hormonal contraceptive use during the pandemic, given the thrombosis risk. Economic downturns, while generally less impactful in South Korea's robust economy, could potentially influence consumer choices towards more affordable options if disposable incomes are constrained. While countries like China lead the regional market in terms of revenue, South Korea stands out for its technological adoption and growing demand for flexible methods.

Contraceptive Drugs, primarily hormonal options, have seen a gradual increase in adoption, particularly low-dose oral contraceptive pills. Oral contraceptive pills are widely available, and while some are over-the-counter, others require a prescription, contributing to a nuanced access landscape. However, their cost, as many are not fully covered by national health insurance, can be a deterrent for consistent use. Emergency contraceptive pills are also available but require a prescription, which can create access barriers, especially in urgent situations. Injectable contraceptives and hormonal patches are also part of this segment, though their market share might be smaller compared to oral contraceptive pills. Contraceptive Devices currently constitute the largest revenue-generating product segment and are also projected to be the fastest-growing. Condoms are by far the most dominant device, widely accepted and easily accessible across South Korea. Their popularity is fueled by their dual protection against pregnancy and sexually transmitted infections, whose prevalence remains a public health concern. Brands like Durex have a strong presence, alongside domestic manufacturers. Intrauterine Devices, including both copper and hormonal types, are available and are increasingly gaining traction as long-acting reversible contraceptives. The subdermal implant is also becoming more popular, offering a highly effective and long-term solution. While these LARCs are highly effective, their adoption rate is still lower than in some Western countries, partly due to a lingering perception of invasiveness, the need for a medical procedure for insertion, and possibly less aggressive promotion compared to oral pills.

15-44 years demographic, which comprises the core reproductive-aged population, contraceptive choices are dynamic. Younger individuals, particularly those sexually active, predominantly rely on condoms for both pregnancy and STI prevention, largely due to their accessibility and the relatively higher social acceptance of male barrier methods. As individuals move into their late 20s and beyond, and particularly within marital or long-term partnerships, there's a growing inclination towards more effective methods. Oral contraceptive pills are increasingly adopted, especially for birth spacing and achieving desired family size flexibility. The uptake of LARCs like IUDs and implants is also gradually increasing in this age group as awareness of their efficacy and convenience grows, though their adoption remains lower than in some Western nations. For the Above 44 years age group, contraceptive needs typically shift towards preventing unintended pregnancies as women approach menopause, or for those who have completed their family size. While the overall fertility rate naturally declines, contraception remains relevant. For this demographic, a continued reliance on barrier methods may persist, or some may opt for permanent methods like sterilization, though these are less common in South Korea compared to other countries. Hormonal methods, if previously used, may be re-evaluated based on perimenopausal symptoms and overall health considerations. Access to accurate information from healthcare providers about appropriate methods for this life stage, including discussions about contraceptive cessation, is important.

Female contraceptive methods bearing the primary burden of family planning, though there's a growing societal discussion about greater Male involvement. Female-centric methods are diverse and widely available, including oral contraceptive pills, injectables, patches, vaginal rings, IUDs, implants, and female sterilization. While the range of options has expanded, allowing women more choice and control over their fertility, the responsibility for birth control largely still rests with them. Concerns about side effects of hormonal methods, often fueled by misinformation, can also affect uptake. The Male contraceptive market in South Korea is overwhelmingly dominated by condoms. Male condoms are highly popular and widely used, primarily for their dual protection against pregnancy and sexually transmitted infections (STIs). Their ease of access and cultural acceptance make them the most common male contraceptive method. Male sterilization, while available, has a significantly lower uptake rate compared to female sterilization, influenced by cultural perceptions and a lingering reluctance among men to undergo permanent procedures. There are virtually no reversible male contraceptive drugs or devices available in the market. Despite increasing awareness of sexual health, many men still refuse condom use, shifting the burden of contraception onto women. This imbalance underscores the need for public health campaigns that actively promote shared contraceptive responsibility and address the cultural and social barriers hindering male engagement in family planning decisions.

Retail pharmacies are the most widespread and convenient access points for many contraceptive products. They are crucial for the widespread availability of condoms, which are readily available over-the-counter. Additionally, certain low-dose oral contraceptive pills can be purchased without a prescription, making pharmacies a key channel for these hormonal methods. However, emergency contraceptive pills still require a prescription, which adds a barrier to immediate access. Hospital pharmacies, particularly those associated with larger hospitals and specialized clinics, serve patients who have received consultations and prescriptions from healthcare providers within those facilities. These are particularly relevant for dispensing methods that require medical oversight, such as injectables, or for procedures like IUD insertion or removal that typically occur in a clinical setting. Online channels are rapidly emerging as a significant and convenient distribution pathway, especially for condoms and other over-the-counter sexual health products. E-commerce platforms offer discretion and ease of purchase, appealing to consumers who might prefer to avoid in-person transactions. While prescription-only hormonal methods cannot be purchased directly without a prescription, online consultations and subsequent delivery of prescribed medications are gaining traction, further enhancing access for some users. Other distribution channels primarily include various medical clinics, particularly obstetrics and gynecology clinics, which are central for comprehensive family planning counseling, prescriptions for a wider range of hormonal methods, and the insertion of LARCs like IUDs and implants.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Contraceptive Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Contraceptive Drugs
• Contraceptive Devices

By Age Group
• 15 - 44 years
• Above 44 years

By Gender
• Female
• Male

By Distribution Channels
• Retail pharmacies
• Hospital pharmacies
• Online channels
• Other distribution channels Show more